首页 | 本学科首页   官方微博 | 高级检索  
     


FKBP12.6 disruption impairs glucose-induced insulin secretion
Authors:Noguchi Naoya  Yoshikawa Takeo  Ikeda Takayuki  Takahashi Iwao  Shervani Nausheen Jamal  Uruno Akira  Yamauchi Akiyo  Nata Koji  Takasawa Shin  Okamoto Hiroshi  Sugawara Akira
Affiliation:a Department of Advanced Biological Sciences for Regeneration (Kotobiken Medical Laboratories), Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Sendai 980-8575, Japan
b Department of Biochemistry, Nara Medical University, Kashihara 634-8521, Japan
c Department of Medical Biochemistry, Iwate Medical University School of Pharmacy, Yahaba-cho 028-3603, Japan
Abstract:Cyclic ADP-ribose (cADPR), accumulated in pancreatic β-cells in response to elevated ATP levels after glucose stimulation, mobilizes Ca2+ from the endoplasmic reticulum through the ryanodine receptor (RyR) and thereby induces insulin secretion. We have recently demonstrated in an in vitro study that cADPR activates RyR through binding to FK506-binding protein 12.6 (FKBP12.6), an accessory protein of RyR. Here we generated FKBP12.6-deficient (FKBP12.6−/−) mice by homologous recombination. FKBP12.6−/− mice showed glucose intolerance coupled to insufficient insulin secretion upon a glucose challenge. Insulin secretion in response to glucose was markedly impaired in FKBP12.6−/− islets, while sulfonylurea- or KCl-induced insulin secretion was unaffected. No difference was found in the glucose oxidation rate between FKBP12.6−/− and wild-type islets. These results indicate that FKBP12.6 plays a role in glucose-induced insulin secretion downstream of ATP production, independently of ATP-sensitive K+ channels, in pancreatic β-cells.
Keywords:FKBP12.6, FK506-binding protein 12.6   cADPR, cyclic ADP-ribose   RyR, ryanodine receptor
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号